CLINICAL_TRIALS
research
· 2018-06-12
Clinical Trial Update: Effects of Dexmedetomidine on Delirium After Living Donor Renal Transplantation in Adult Patients [Phase 4]
Summary
A Phase 4 clinical trial evaluating the effect of dexmedetomidine on delirium after living donor renal transplantation in adults. The trial status is currently …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Tao Zhang | Conditions: Postoperative Delirium After Living Donor Renal Transplantation | Phase 4 | Status: UNKNOWN